iLoF
PrivateLast Round
SAFE
Mar 9, 2026
Total Funding Raised
$12.67M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
iLoF operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a SAFE round in March 2026.
iLoF is a digital health company with an AI and photonics platform that creates a digital library of biomarkers to accelerate personalized drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Clinical Trials, Medical AI, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
iLoF Comparables
Compare iLoF with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sonrai Analytics | 81% | |
| Aignostics | 73% | |
| Insitro | 65% |
For institutional investors. Book with your work email.
iLoF Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| SAFE | Mar 9, 2026 | ||||
| Strategic | Oct 22, 2024 | ||||
| Grant | Jul 31, 2024 | ||||
| Accelerator | Jan 1, 2023 | ||||
| Seed | Jul 28, 2022 | ||||
Grant | Jul 28, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
iLoF Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hamamatsu Ventures | SAFE, Strategic |
| European Innovation Council Fund | Accelerator |
| EIT Health | Accelerator |
| European Regional Development Fund | Grant |
| re.Mind Capital | Seed |
| M12 - Microsoft's Venture Fund | SAFE, Seed |
| EIT Health InnoStars Awards | SAFE |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors increased 43% MoM.
- Jun 23, 2026
Monthly visitors grew 122% MoM, reaching 3K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 30, 2026
iLoF partners with Hamamatsu Corporation, a Japanese investor, after joining a London & Partners trade mission to Japan and attending the BioJapan health tech fair.
For institutional investors. Book with your work email.
iLoF Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about iLoF's valuation, stock price, and market status.
Is iLoF a public or private company?
iLoF is a private company.
What is the current stock price of iLoF?
iLoF is a private company, so its shares have no public market price. Caplight tracks iLoF's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is iLoF worth (valuation)?
Valuation information for iLoF is not publicly available.
Can I buy iLoF stock?
iLoF shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was iLoF's last funding round?
iLoF's most recent funding round was SAFE on March 9, 2026.
Who are the main investors in iLoF?
Key investors in iLoF include Faber Ventures.
Will iLoF IPO soon?
No public IPO plans have been announced for iLoF.
How can I track iLoF secondary market activity?
Caplight tracks bids, offers, and trades in iLoF's shares on secondary markets.